Survival analysis in the presence of competing risks

被引:127
作者
Zhang, Zhongheng [1 ]
机构
[1] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Emergency Med, Hangzhou 310016, Zhejiang, Peoples R China
关键词
Competing risk; Fine-Gary model; hazard function; cumulative incidence; CUMULATIVE INCIDENCE; REGRESSION; HAZARDS; MODELS;
D O I
10.21037/atm.2016.08.62
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Survival analysis in the presence of competing risks imposes additional challenges for clinical investigators in that hazard function (the rate) has no one-to-one link to the cumulative incidence function (CIF, the risk). CIF is of particular interest and can be estimated non-parametrically with the use cuminc() function. This function also allows for group comparison and visualization of estimated CIF. The effect of covariates on cause-specific hazard can be explored using conventional Cox proportional hazard model by treating competing events as censoring. However, the effect on hazard cannot be directly linked to the effect on CIF because there is no one-to-one correspondence between hazard and cumulative incidence. Fine-Gray model directly models the covariate effect on CIF and it reports subdistribution hazard ratio (SHR). However, SHR only provide information on the ordering of CIF curves at different levels of covariates, it has no practical interpretation as HR in the absence of competing risks. Fine-Gray model can be fit with crr() function shipped with the cmprsk package. Time-varying covariates are allowed in the crr() function, which is specified by cov2 and tf arguments. Predictions and visualization of CIF for subjects with given covariate values are allowed for crr object. Alternatively, competing risk models can be fit with riskRegression package by employing different link functions between covariates and outcomes. The assumption of proportionality can be checked by testing statistical significance of interaction terms involving failure time. Schoenfeld residuals provide another way to check model assumption.
引用
收藏
页数:9
相关论文
共 12 条
[1]   Competing risks in epidemiology: possibilities and pitfalls [J].
Andersen, Per Kragh ;
Geskus, Ronald B. ;
de Witte, Theo ;
Putter, Hein .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2012, 41 (03) :861-870
[2]   Interpretability and importance of functionals in competing risks and multistate models [J].
Andersen, Per Kragh ;
Keiding, Niels .
STATISTICS IN MEDICINE, 2012, 31 (11-12) :1074-1088
[3]   Practical methods for competing risks data: A review [J].
Bakoyannis, Giorgos ;
Touloumi, Giota .
STATISTICAL METHODS IN MEDICAL RESEARCH, 2012, 21 (03) :257-272
[4]   A proportional hazards model for the subdistribution of a competing risk [J].
Fine, JP ;
Gray, RJ .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1999, 94 (446) :496-509
[5]   Absolute risk regression for competing risks: interpretation, link functions, and prediction [J].
Gerds, Thomas A. ;
Scheike, Thomas H. ;
Andersen, Per K. .
STATISTICS IN MEDICINE, 2012, 31 (29) :3921-3930
[6]   A CLASS OF K-SAMPLE TESTS FOR COMPARING THE CUMULATIVE INCIDENCE OF A COMPETING RISK [J].
GRAY, RJ .
ANNALS OF STATISTICS, 1988, 16 (03) :1141-1154
[7]   Applying competing risks regression models: an overview [J].
Haller, Bernhard ;
Schmidt, Georg ;
Ulm, Kurt .
LIFETIME DATA ANALYSIS, 2013, 19 (01) :33-58
[8]   A competing risks analysis should report results on all cause-specific hazards and cumulative incidence functions [J].
Latouche, Aurelien ;
Allignol, Arthur ;
Beyersmann, Jan ;
Labopin, Myriam ;
Fine, Jason P. .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2013, 66 (06) :648-653
[9]   A note on competing risks in survival data analysis [J].
Satagopan, JM ;
Ben-Porat, L ;
Berwick, M ;
Robson, M ;
Kutler, D ;
Auerbach, AD .
BRITISH JOURNAL OF CANCER, 2004, 91 (07) :1229-1235
[10]   Heparin or 0.9% sodium chloride to maintain central venous catheter patency: A randomized trial [J].
Schallom, Marilyn E. ;
Prentice, Donna ;
Sona, Carrie ;
Micek, Scott T. ;
Skrupky, Lee P. .
CRITICAL CARE MEDICINE, 2012, 40 (06) :1820-1826